Dashboard
Manage Tickers

TXG10x Genomics, Inc.

Nasdaq 10xgenomics.com


$ 19.40 $ -0.40 (-2.02 %)    

Friday, 28-Jun-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 19.45
$ 19.95
$ 0.00 x 0
$ 0.00 x 0
$ 19.26 - $ 20.36
$ 18.39 - $ 63.57
3,293,192
na
2.32B
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-16-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-18-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-12-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

barclays-maintains-overweight-on-10x-genomics-lowers-price-target-to-24
Barclays Maintains Overweight on 10x Genom...
06/28/2024 15:36:33

Barclays analyst Luke Sergott maintains 10x Genomics (NASDAQ:TXG) with a Overweight and lowers the price target from $36 to ...

10x-genomics-shares-are-trading-lower-after-wolfe-research-downgraded-the-stock-from-outperform-to-peer-perform
10x Genomics shares are trading lower afte...
06/27/2024 14:16:41

wolfe-research-downgrades-10x-genomics-to-peer-perform
Wolfe Research Downgrades 10x Genomics to ...
06/27/2024 09:49:43

Wolfe Research analyst Doug Schenkel downgrades 10x Genomics (NASDAQ:TXG) from Outperform to Peer Perform.

cathie-woods-ark-invest-acquires-73m-worth-of-shares-in-this-promising-netflix-competitor-sells-off-coinbase-stock-amid-bitcoin-slump
Cathie Wood's Ark Invest Acquires $7.3M Wo...
06/27/2024 03:33:17

On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN...

guggenheim-downgrades-10x-genomics-to-neutral
Guggenheim Downgrades 10x Genomics to Neutral
06/26/2024 17:08:04

Guggenheim analyst Subbu Nambi downgrades 10x Genomics (NASDAQ:TXG) from Buy to Neutral.

cathie-wood-led-ark-invest-dumps-43m-worth-of-nvidia-shares-amid-rebound--swoops-into-buy-stock-of-this-netflix-rival
Cathie Wood-Led Ark Invest Dumps $4.3M Wor...
06/26/2024 02:27:55

analyst-scoreboard-9-ratings-for-10x-genomics
Analyst Scoreboard: 9 Ratings For 10x Geno...
06/25/2024 14:00:32

guggenheim-downgrades-10x-genomics-to-neutral
Guggenheim Downgrades 10x Genomics to Neutral
06/25/2024 12:01:28

Guggenheim analyst Subbu Nambi downgrades 10x Genomics (NASDAQ:TXG) from Buy to Neutral.

10x-genomics-begins-commercial-shipments-of-its-xenium-prime-5k-pan-tissue-and-pathways-panel
10x Genomics Begins Commercial Shipments O...
06/20/2024 13:02:32

unveiling-9-analyst-insights-on-10x-genomics
Unveiling 9 Analyst Insights On 10x Genomics
06/03/2024 18:01:03

jefferies-initiates-coverage-on-10x-genomics-with-hold-rating-announces-price-target-of-24
Jefferies Initiates Coverage On 10x Genomi...
06/03/2024 17:59:59

Jefferies analyst Tycho Peterson initiates coverage on 10x Genomics (NASDAQ:TXG) with a Hold rating and announces Price Targ...

10x-genomics-launches-xenium-prime-5k-pan-tissue-and-pathways-panel
10x Genomics Launches Xenium Prime 5K Pan-...
05/29/2024 20:36:11

 New Xenium Prime 5K Pan-Tissue and Pathways panel increases plex by an order of magnitude and delivers industry-leading speed ...

cathie-woods-ark-innovation-etf-sees-sharp-decline-among-top-holdings--here-are-10-largest-losers-within-arkf
Cathie Wood's Ark Innovation ETF Sees Shar...
05/28/2024 11:29:37

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced b...

Core News & Articles
German Federal Patent Court Invalidates Eu...
05/07/2024 18:09:43

Core News & Articles
German Federal Patent Court Invalidates Pa...
05/07/2024 18:08:08

NanoString, now a Bruker business, will promptly seek an end to the injunction impacting sales of CosMx SMI products in Germany...

ubs-maintains-neutral-on-10x-genomics-lowers-price-target-to-30
UBS Maintains Neutral on 10x Genomics, Low...
05/01/2024 17:34:33

UBS analyst Dan Leonard maintains 10x Genomics (NASDAQ:TXG) with a Neutral and lowers the price target from $52 to $30.

b-of-a-securities-maintains-neutral-on-10x-genomics-lowers-price-target-to-36
B of A Securities Maintains Neutral on 10x...
05/01/2024 17:10:13

B of A Securities analyst Derik De Bruin maintains 10x Genomics (NASDAQ:TXG) with a Neutral and lowers the price target from...

goldman-sachs-maintains-sell-on-10x-genomics-lowers-price-target-to-26
Goldman Sachs Maintains Sell on 10x Genomi...
05/01/2024 16:39:42

Goldman Sachs analyst Matthew Sykes maintains 10x Genomics (NASDAQ:TXG) with a Sell and lowers the price target from $30 to ...

td-cowen-downgrades-10x-genomics-to-hold-lowers-price-target-to-32
TD Cowen Downgrades 10x Genomics to Hold, ...
05/01/2024 16:27:36

TD Cowen analyst Dan Brennan downgrades 10x Genomics (NASDAQ:TXG) from Buy to Hold and lowers the price target from $57 to $32.

stifel-maintains-buy-on-10x-genomics-lowers-price-target-to-53
Stifel Maintains Buy on 10x Genomics, Lowe...
05/01/2024 13:01:52

Stifel analyst Daniel Arias maintains 10x Genomics (NASDAQ:TXG) with a Buy and lowers the price target from $63 to $53.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)